Phase III Trial Pembrolizumab is Better Than Ipilimumab for Advanced Melanoma

Phase III Trial Pembrolizumab is Better Than Ipilimumab for Advanced Melanoma

GiantsOfCancerCare

4 years
580 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Jason Luke, MD of the University of Chicago discusses Phase III Trial Pembrolizumab is Better Than Ipilimumab for Advanced Melanoma
Up Next Autoplay
Reducing opioids in breast cancer surgery using Bupivacaine
Reducing opioids in breast cancer surgery using Bupivacaine
Category: Acute Lymphoblastic Leukemia
678 Views
GiantsOfCancerCare 4 years
Management of Hot Flashes using SSRI, Gabapentin, Venlafaxine in patients with breast cancer
Management of Hot Flashes using SSRI, Gabapentin, Venlafaxine in patients with breast cancer
Category: Acute Lymphoblastic Leukemia
908 Views
GiantsOfCancerCare 4 years
Olanzapine Decreases Nausea and Vomiting in Patients With Esophageal, Head and Neck Cancer
Olanzapine Decreases Nausea and Vomiting in Patients With Esophageal, Head and Neck Cancer
Category: Acute Lymphoblastic Leukemia
534 Views
GiantsOfCancerCare 4 years
Scrambler therapy for the treatment of chemotherapy- induced peripheral neuropathy
Scrambler therapy for the treatment of chemotherapy- induced peripheral neuropathy
Category: Acute Lymphoblastic Leukemia
379 Views
GiantsOfCancerCare 4 years
I-SPY 2 and MK-2206 Shows Benefit For Breast Cancer Patients
I-SPY 2 and MK-2206 Shows Benefit For Breast Cancer Patients
Category: Acute Lymphoblastic Leukemia
504 Views
GiantsOfCancerCare 4 years
Checkpoint Inhibitors in Triple Negative Breast Cancer
Checkpoint Inhibitors in Triple Negative Breast Cancer
Category: Acute Lymphoblastic Leukemia
404 Views
GiantsOfCancerCare 4 years
CDK 4/6 Inhibitor Improves PFS for Patients with HR+/HER- Breast Cancer
CDK 4/6 Inhibitor Improves PFS for Patients with HR+/HER- Breast Cancer
Category: Acute Lymphoblastic Leukemia
498 Views
GiantsOfCancerCare 4 years
Scalp cooling system prevented significant hair loss in 70.3% of patients with breast cancer receiving adjuvant CTX
Scalp cooling system prevented significant hair loss in 70.3% of patients with breast cancer receiving adjuvant CTX
Category: Acute Lymphoblastic Leukemia
305 Views
GiantsOfCancerCare 4 years
Phase II Androgen Deprivation Therapy with Palbociclib
Phase II Androgen Deprivation Therapy with Palbociclib
Category: Acute Lymphoblastic Leukemia
750 Views
GiantsOfCancerCare 4 years
ETS Gene Fusions as a Predictive Biomarker in Prostate Cancer
ETS Gene Fusions as a Predictive Biomarker in Prostate Cancer
Category: Acute Lymphoblastic Leukemia
771 Views
GiantsOfCancerCare 4 years